Last patient last visit (LPLV) milestone in AFFIRM-1 Phase 3 trial of BNC-210 in social anxiety disorder (SAD) achieved; ...
A group is exploring working with the Greeley and Catalyst developers to make sure the community gets the most benefits from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback